Freemont Management S.A. Purchases 7,300 Shares of MetLife, Inc. $MET

Posted by Brian Himes on May 14th, 2026

Freemont Management S.A. grew its stake in MetLife, Inc. (NYSE:MET – Free Report) by 197.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 11,000 shares of the financial services provider’s stock after buying an additional 7,300 shares during the quarter. Freemont Management S.A.’s holdings in MetLife were worth $868,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Trustmark Bank Trust Department grew its stake in MetLife by 4.6% in the 3rd quarter. Trustmark Bank Trust Department now owns 2,870 shares of the financial services provider’s stock worth $236,000 after buying an additional 127 shares in the last quarter. Cornerstone Wealth Group LLC grew its stake in MetLife by 4.9% in the 3rd quarter. Cornerstone Wealth Group LLC now owns 2,790 shares of the financial services provider’s stock worth $230,000 after buying an additional 130 shares in the last quarter. UMB Bank n.a. grew its stake in MetLife by 1.9% in the 3rd quarter. UMB Bank n.a. now owns 7,040 shares of the financial services provider’s stock worth $580,000 after buying an additional 132 shares in the last quarter. Johnson Investment Counsel Inc. grew its stake in MetLife by 1.0% in the 3rd quarter. Johnson Investment Counsel Inc. now owns 13,908 shares of the financial services provider’s stock worth $1,146,000 after buying an additional 134 shares in the last quarter. Finally, Trust Co. of Toledo NA OH grew its stake in MetLife by 0.5% in the 4th quarter. Trust Co. of Toledo NA OH now owns 30,431 shares of the financial services provider’s stock worth $2,402,000 after buying an additional 138 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on MET shares. Wells Fargo & Company boosted their price target on shares of MetLife from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Tuesday. Mizuho set a $95.00 price target on shares of MetLife in a research note on Friday, May 8th. Bank of America cut their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. UBS Group boosted their price target on shares of MetLife from $98.00 to $102.00 and gave the stock a “buy” rating in a research note on Thursday, April 9th. Finally, Evercore set a $96.00 price objective on shares of MetLife in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.15.

View Our Latest Stock Report on MET

MetLife Price Performance

Shares of MetLife stock opened at $78.05 on Thursday. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $83.85. The stock has a market capitalization of $50.22 billion, a price-to-earnings ratio of 15.13, a price-to-earnings-growth ratio of 0.69 and a beta of 0.78. The company has a fifty day moving average of $73.65 and a 200-day moving average of $76.52. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.20 and a current ratio of 0.20.

MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The financial services provider reported $2.42 EPS for the quarter, beating the consensus estimate of $2.27 by $0.15. The firm had revenue of $14.18 billion during the quarter, compared to the consensus estimate of $19.49 billion. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.96 earnings per share. Equities research analysts expect that MetLife, Inc. will post 9.9 EPS for the current year.

MetLife Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 12th will be issued a $0.5925 dividend. This is a boost from MetLife’s previous quarterly dividend of $0.57. The ex-dividend date is Tuesday, May 12th. This represents a $2.37 annualized dividend and a yield of 3.0%. MetLife’s dividend payout ratio (DPR) is currently 45.93%.

MetLife News Summary

Here are the key news stories impacting MetLife this week:

Positive Sentiment: Keefe, Bruyette & Woods lifted its price target on MetLife to $98 from $87 and kept an outperform rating, implying meaningful upside from current levels.
Positive Sentiment: JPMorgan raised its price target on MetLife to $96 from $95 and maintained an overweight rating, reinforcing a bullish outlook for the insurer.
Positive Sentiment: MetLife announced or was linked to several healthcare partnership updates, including direct billing for obesity care in the UAE and a virtual care partnership with Mediclinic Middle East, which may help strengthen its employee benefits and health-focused offerings. Lilly and MetLife introduce direct billing model for obesity care for Lilly employees in the UAE Mediclinic Middle East and MetLife partner to deliver nationwide access to virtual care
Neutral Sentiment: Recent articles about MetLife Stadium and World Cup ticket, seating, and transportation issues are centered on the venue name, not MetLife, Inc.’s insurance operations, so they are unlikely to have a direct impact on the stock. See which MetLife World Cup resale ticket prices are rising and falling MetLife Seating Chart: How to find the best seats for the World Cup World Cup train, bus tickets from NYC to MetLife Stadium get another price cut MetLife Stadium travel workaround found which cuts round-trip price to $20 for World Cup The NY Giants are opening 2026 at MetLife against the Cowboys. Get tickets now

MetLife Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.